## Abstract In an attempt to detect and characterize immunoglobulins fixed in vivo onto tumor cells, a low pH buffer was used to dissociate the tumor cells from the bound immunoglobulins. IgG2 could be eluted from intact cells and from a membrane‐rich‐sub‐cellular fraction originating from primary
Tumor-associated immunoglobulins. enhancement of syngeneic tumors by igg2-containing tumor eluates
✍ Scribed by Maya Ran; Isaac P. Witz
- Book ID
- 102275988
- Publisher
- John Wiley and Sons
- Year
- 1972
- Tongue
- French
- Weight
- 462 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The present study was intended to establish whether IgG2‐containing eluates, dissociated from carcinogen‐induced tumors by a low pH buffer, have tumor‐enhancing properties.
Threshold amounts of cells from mouse tumor lines originally induced by benzo (a)‐pyrene or by methylcholanthrene were mixed and incubated, prior to inoculation, with IgG2‐containing eluates, originating either from the corresponding tumors (autologous eluates) or from other syngeneic tumors (isologous eluates). Tumor cells incubated and injected together with autologous eluates gave in some experiments a higher yield of tumors in syngeneic mice than did cells not subjected to this treatment. Some isologous eluates originating from several primary tumors or from syngeneic tumors belonging to a different line from the one tested, were also capable of enhancing tumor growth.
📜 SIMILAR VOLUMES
## Abstract Transplanted lines of 3‐methylcholanthrene (MCA)‐induced BALB/c sarcomas were used for experiments in which tumors were mechanically suspended in Waymouth's culture medium, the suspensions centrifuged and filtered and the remaining cell‐free “tumor fluids” (TF) tested for activity __in
## Abstract The phenotypes of the affector and effector cell populations involved during the induction of permanent tumor regression by combined therapy using cyclophosphamide (CY) and immune spleen cells were identified. Permanent tumor regression was dependent on the presence of Thy‐1^+^ Lyt‐2^+^
## Abstract Two monoclonal antibodies (KH‐1 and KH‐2) against a transplanted fibrosarcoma (KMT‐17) in WKA rats were produced by fusing a mouse myeloma (P~3~‐X63‐Ag8.653) with spleen cells from syngeneic rats hyperimmunized with KMT‐17. Both antibodies showed complement‐dependent cytotoxicity agains